Neuropathologic validation of the Alzheimer's Questionnaire
- PMID: 36031683
- PMCID: PMC10165893
- DOI: 10.1007/s40520-022-02222-9
Neuropathologic validation of the Alzheimer's Questionnaire
Abstract
The Alzheimer's Questionnaire (AQ) is an informant-based screening tool with good diagnostic accuracy for Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI). The aim of this study is to validate the AQ with AD-associated neuritic plaque (NP) and neurofibrillary tangle (NFT) pathology. Data from 205 prospectively followed autopsy cases clinically classified as AD (n = 90), aMCI (n = 42), or cognitively unimpaired (CU, n = 73) were used. Semi-quantitative measures of NP and NFT pathology were correlated with the AQ, Clinical Dementia Rating Sum of Boxes (CDR-SOB), and the Mini-Mental State Exam (MMSE). The AQ correlated significantly (p < 0.001) with NP load (r = 0.37) and NFT load (r = 0.57). The MMSE and CDR-SOB showed similar correlations with NP load (r = - 0.37, r = 0.35, respectively) and NFT load (r = - 0.58, r = 0.55, respectively). The AQ correlates well with NP and NFT pathology of AD, which provides additional confidence to clinicians using the AQ to screen for AD-related cognitive impairment.
Keywords: Amyloid plaque; Dementia; Informant-based assessment; Neurofibrillary tangle; Neuropathology.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Figures
References
-
- Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurol 43:2412–2414 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous